tiprankstipranks
Protara Therapeutics (TARA)
NASDAQ:TARA

Protara Therapeutics (TARA) Ownership - Who Owns Protara Therapeutics?

538 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 11, 2024Sold$175502
Jul 03, 2024Sold$17571
Jun 28, 2024Sold$142039
Jun 27, 2024Sold$28631

Recent Hedge Fund Trading Activity

Currently, No Data Available
Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,175,882Insider10.57%5,135,082
2,144,517Insider10.42%5,061,060
2,144,517Insider10.42%5,061,060
1,943,059Insider9.44%4,585,619
1,387,198Insider6.74%3,273,787
1,165,344Insider5.66%2,750,212
424,969Institution2.06%1,002,927
424,969Institution2.06%1,002,927
199,671Institution0.97%471,224
128,249Insider0.62%302,668

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
424,969Institution2.06%1,002,927
72,568Institution0.35%171,260
59,000Institution0.29%139,240
10,563Institution0.05%24,929
946Institution<0.01%2,233
372Institution<0.01%878

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
284,301Institution1.38%798,886
140,668Institution0.68%395,277
38,964Institution0.19%91,955

FAQ

Who Owns Protara Therapeutics (TARA)?
Currently, no data Available
What percentage of Protara Therapeutics (TARA) stock is held by institutional investors?
Currently, no data Available
What percentage of Protara Therapeutics (TARA) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Protara Therapeutics (TARA)?
John Gordon Freund owns the most shares of Protara Therapeutics (TARA).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis